INTRODUCTION
Natural killer (NK) cells originate in the bone marrow from a CD34ϩLin-CD45RAϩCD10ϩ common lymphoid progenitor cell, which gives rise to CD56ϩ CD3-NK cells, B cells, and dendritic cells [1] . Initial studies showed that CD56ϩCD3-NK cell differentiation from CD34ϩ bone marrow cells required interleukin-2 (IL-2) and bone marrow stromal cells [2] [3] [4] . However, further studies showed that the stromal requirement for CD56ϩCD3-cell differentiation can be substituted with a combination of IL-2 and stem cell factor (SCF) [5] [6] [7] [8] . Although IL-2 initiates CD56ϩCD3-cell differentiation from CD34ϩ, in vitro bone marrow stromal cells do not secrete this cytokine. It is, therefore, not clear whether IL-2 is physiologically involved in NK differentiation. IL-15, which shares IL-2 ␥ and ␤ chains with IL-2, may be a more physiologically relevant cytokine, as it is produced by bone marrow stroma and can induce CD34ϩ cells to generate CD56ϩCD3-cells [8] . It is remarkable that most studies of NK development have used IL-2 and IL-15 with CD34ϩ cells isolated from bone marrow [2, 3, 5, [7] [8] [9] [10] [11] [12] [13] [14] or cord blood [14 -19] . With the exception of one study [20] , little is known about the effects of IL-2 on the generation of CD56ϩCD3-cells from granulocytecolony stimulating factor (G-CSF)-mobilized CD34ϩ cells. Considering that the use of G-CSF-mobilized CD34ϩ cell transplantation has become a common practice [21] , it is important to investigate their ability to generate NK cells, as they may regulate graft-versus-host and graft-versus-leukemia effects following allogeneic stem cell transplantation. To further study the early stages and regulatory pathways of CD56ϩCD3-cell development from CD34 cells, we cultured purified, G-CSF-mobilized CD34 cells obtained from healthy stem cell donors in growth conditions favorable to CD56ϩCD3-cell growth and differentiation. Here, we describe two populations of CD56ϩ cells emerging after 3 weeks of culture, which can be separated into a CD56 bright NK precursor and a novel CD56 dim monocytic cell population.
MATERIALS AND METHODS

Antibodies and reagents
Fluorescein isothiocyanate (FITC)-conjugated anti-CD56, anti-Fc receptor for immunoglobulin G (IgG; Fc␥R)III (CD16), anti-Fc␥RII (CD32), anti-CD33, 
Flow cytometric analysis
In some experiments, cells were stained with PE-conjugated anti-CD56 or anti-c-kit (one color). In other experiments, cells were incubated with FITC anti-CD56 and PE anti-c-kit (two colors) or a combination of PE, FITC, PerCP, and APC-conjugated antibodies specific for the desired molecules (four colors). In all cases, the cells were stained at 0°C for 30 min, washed twice, and fixed in 1% paraformaldehyde (PFA). For intracellular staining experiments, 10 6 cells were first stained with a PE-conjugated anti-CD56 for 15 min at room temperature (RT) in the dark, and then 2 ml fluorescein-activated cell sorter (FACS) lysing solution was added to the cell mixture. After 10 min incubation at RT, cells were washed and permeabilized with 0.5 ml FACS perm mix for 10 min at RT. Cells were than stained with a FITC-conjugated anti-granzyme A mAb or FITC-conjugated mouse control mAb isotypes for 30 min at RT, washed, and fixed in 200 l 1% PFA. Cells were analyzed by a Becton Dickinson FACSCaliber flow cytometer.
Microcytotoxicity assay
Effector cells were resuspended at the concentration of 8 ϫ 10 5 /ml in CM. Replicates of 20 l (1.6ϫ10 4 ) effector cells were incubated in a 60-well (40 l depth) Terasaki plate for 30 min at RT. At the same time, 2 ϫ 10 6 P815 cells were incubated in 1 ml CM supplemented with 10 l calcein-AM (Molecular Probes, Junction City, OR) for 30 min at 37°C, washed four times, and diluted to 1 ϫ 10 5 /ml. After diluting the effector cells, 10 l (1ϫ10 3 ) target cells were added, and plates were centrifuged and incubated at 37°C for 4 h. A few minutes before scanning the plates using a fluorescent detector, 5 l fluoro-quench was added to each well. The percent of lysis was calculated as follows: 1 -(mean test-mean blank)/(mean max-mean blank) ϫ 100.
Proliferation assay
The proliferation of P815 cells was measured by tritiated thymidine ( 3 H-TdR) incorporation. The first three U-wells of each horizontal row of 96-well plates were filled with 200 l (1.6ϫ10 4 ) of negatively selected NK cells or positively selected peripheral blood CD56ϩ cells, and then 100 l cultured cells were serially diluted in the remaining wells previously filled with 100 l CM. Later, 1 ϫ 10 3 P815 cells were added to the cell cultures. After 2 days incubation, cells were pulsed with 1 Ci 3 H-TdR per well (Amersham Biosciences, Piscataway, NJ). Eighteen hours later, 3 H-TdR was measured using a ␤ scintillation counter.
Cytokine arrays
CD56ϩCD33ϩ cell supernatants cultured in the presence or absence of lipopolysaccharide (LPS) were assessed for cytokine content with a 42 human cytokine array system RayBio TM (RayBiotech, Norcross, GA), which detects the antibody-cytokine sandwich by chemiluminescence. Briefly, electronically sorted cells were cultured in duplicate with or without LPS in 96-well U-bottom plates, and the cumulative amount of supernatants was harvested and replaced with CM at 24, 48, and 72 h and stored frozen in a single pool until use. Antibody-coated membranes (duplicates) were incubated in 2 ml blocking buffer for 30 min. Cryopreserved supernatants were thawed, diluted 1:1 with blocking buffer, and added to the membranes. After 2 h incubation at RT after agitation, membranes were washed five times and incubated with a cocktail of biotin-conjugated antibodies. After 2 h, membranes were washed five times and incubated for 30 min with horseradish peroxidase-conjugated streptavidin. Membranes were incubated in the detection system for 5 min, wrapped in plastic wrap, placed in a Kodak cassette, and exposed to a X-OMAT for various periods of time.
IL-8 and IL-1␤ measurement
Electronically sorted CD56ϩ or CD56 -cells were cultured in CM. Supernatants were harvested at 72 h and stored frozen in a single pool. IL-8 content was by a standard immunoassay (Biosource, Camarillo, CA), IL-1␤ was purchased from R&D Systems (Minneapolis, MN), and interferon-␣ (IFN-␣) was purchased from PBL Biomedical Laboratories (Piscataway, NJ).
RESULTS
Phenotype and morphology of cultured CD34 cells
A total number of 2.5 Ϯ 2.8 ϫ 10 6 (nϭ11) G-CSF-mobilized CD34 cells were cultured in the presence of IL-2 200 U/ml and SCF 50 ng/ml. After 2 weeks of culture, a fraction of 3.4 Ϯ 2.4 ϫ 10 6 nonadherent, hematopoietic cells was analyzed by flow cytometry. The majority of the cells in culture was CD33ϩ ( Table 1) . In 11 normal stem cell donors studied, there was a minor population of CD56ϩ cells segregating into CD56 bright (7Ϯ10 range 0.2-34%) and CD56 dim (2.5Ϯ2.0 range 0.38 -5%). Flow-sorted CD56ϩ and CD56 -cells stained with Giemsa showed that the CD56ϩ population was a heterogeneous mixture of large granular lymphocytes (LGL) and cells with myeloid or plasmacytoid appearance. The CD56 -fraction was also heterogeneous but lacked LGL (Fig. 1A) . The phenotype of the CD56ϩ cells was examined further for NK cell markers and integrins ( 
CD33 expression
CD56ϩ cells from 3-week CD34ϩCD33-cell cultures were sorted and resuspended in SCF and IL-2. In six individuals, CD56ϩ cells were CD56 dim CD33ϩ (40.5Ϯ29) and had macrophage morphology, and the remaining cells CD56ϩCD33-resembled LGL (Fig. 1B) . Most individuals also had a minor population of CD56 dim CD33-cells, and in five of 13 independent analyses of G-CSF-mobilized CD34 products derived from six individuals, we found a minor population of CD56 (Fig. 2) .
Functional assays of CD56ϩ cells
CD56ϩ cells were flow-sorted into bright and dim populations and cultured with high doses of LPS. In three consecutive donors, CD56 dim CD33ϩ cells promptly incorporated 3 H-TdR and proliferated in culture, and CD56 bright CD33-cells did not ( Table 2) . Monocyte-macrophages have antiproliferative properties but lacked perforin-dependent cytotoxicity [23, 24] . CD56 dim CD33ϩ cells targeted against the P815 cell line, as a classical NK cell target inhibited P815 proliferation but was not cytotoxic in a 4-h cytotoxicity assay, suggesting that CD56 dim CD33ϩ cells behaved like monocyte-macrophages ( Table 3) .
Cytokine production CD34-derived NK cells generated in vitro produce minimal levels of IFN-␥, tumor necrosis factor ␣, and granulocyte macrophage-CSF but can up-regulate these cytokines upon activation [8] . We therefore studied cytokine production in CD56ϩ cell CM in a cytokine array. To further validate the cytokine array data, we measured the IL-8 content of CD56 dim CD33ϩ and CD56 bright CD33-cell culture-conditioning medium by an immunoenzymatic assay. The IL-1␤ content was used as a negative control. In unstimulated, CD56-derived CD34ϩ cells, the amount of IL-8 detected in CD56 dim CD33ϩ cell culture CM (8.6Ϯ2.2 ng/ml) was tenfold higher than the IL-8 content measured in the CM of CD56 bright CD33ϩ cells (0.9Ϯ1.2), and in both cases, no IL-1␤ was detected. These results showed that the cytokine production in the two CD56 populations was quantitatively and qualitatively different.
CD56ϩ cell generation is inhibited by IL-4 and HA acid
As IL-4 and HA are produced by marrow stromal cells and regulate hematopoiesis [25, 26] , we studied their effect on CD56ϩ cell development. IL-4 enhanced CD34ϩ cell proliferation in SCF ϩ IL-2, and HA had an antiproliferative effect. Three-week cultures of CD34 cells in IL-4 and HA inhibited CD56ϩ cell development. Without HA and IL-4, 32% of CD34ϩ cells were CD56ϩ, and only 9% and 1.5% were CD56ϩ in HA and IL-4, respectively. Cultures remained Ͼ95% viable by trypan blue (Fig. 4) .
DISCUSSION
Several recent studies, investigating the in vitro growth of CD34 cells in IL-2 in the absence of marrow stroma, have described the induction of CD3-CD56ϩ functionally competent NK cells as well as a minor population of CD16ϩ cells [2, 5, 9] . To further study in vitro generation of NK cells from G-CSF-mobilized CD34ϩ cells derived from normal donors, we cultured them in combinations of SCF and IL-2. As CD56 (a 120-to 180-KD N-linked, glycosylated isoform of the neural cell adhesion molecule) [27] is a useful marker for NK cells and a subset of dendritic cells, we studied the emergence of CD56ϩ cells in culture. It is surprising that we found that after 2-to 3-week cultures, only 8.7 Ϯ 8.8% of cultured cells expressed CD56, about eightfold less than described previously [2, 5, 9] . The majority of cells in our cultures was of myeloid morphology and CD33ϩ, Fc␥RI, or Fc␥RIIϩ. Here, we describe the phenotype and function of cultured CD56ϩ cells, which include a novel myeloid subset of CD56 dim CD33ϩ cells. They have the appearance of macrophages, express integrins, but lack NK cell markers such as KIR and granzyme A. Functionally, they are unable to kill the NKresistant line P815 but exert a cytostatic effect on it. Finally, they constitutively produced IL-8 and up-regulated MCP-1 on stimulation with LPS. We also found a CD56 bright subset, which appears to be immature NK precursors. They possess granzyme A but not granzyme B and do not express KIR or activation markers. Prolongation of some cultures to 70 days ultimately generated small numbers of NK cells with a more mature phenotype as described by others [18] (data not shown).
It is not clear why our results differ from the earlier descriptions of rapid NK cell induction from CD34 cells using the same cytokines or from a recently described CD34 cell-derived NK cell from cord blood [19] . One possibility is that a different source of CD34ϩ cells, including bone marrow, peripheral blood, and umbilical cord blood, may have different frequencies of hematopoietic precursors. Alternatively, the use of G-CSF-mobilized CD34 cells may have resulted in the induc- Fig. 3 . Cytokine production. G-CSF-mobilized CD34 from two donors (Donors 1 and 2) were cultured for 3 weeks with SCF ϩ IL-2, and CD56 dim CD33ϩ and CD56ϩCD33-were electronically sorted and cultured in the presence or absence of LPS. A cumulative amount of supernatants harvested within 72 h and tested for cytokine content. 8, 6 , and 10, IL-8, IL-6, and IL-10, respectively; MCP1, monocyte chemoattractant protein-1; MDC, macrophage-derived chemokine; GRO, growth-related oncogene; I309, CC chemokine. tion of a precursor not present in bone marrow. It is also possible that the absence of marrow stromal cells in culture may have biased the maturation toward CD56ϩCD33ϩ cells, as suggested by the inhibitory effects of HA and IL-4 on CD56ϩ cell development. The physiological significance of these cells is not known. However, it is likely that the cultured CD33ϩCD56ϩ cells are the in vitro counterparts of low frequency, circulating CD56 low CD33ϩ monocytes, which we recently identified (manuscript submitted). It is interesting that these cells share features of the rare CD56ϩCD33ϩ hybrid NK/myeloid leukemia. This aggressive leukemia is represented by two phenotypes: HLA-DR-CD16 -and HLA-DRϩ CD34 -CD7ϩ [28, 29] . The cells we identified appear to be distinct from the plasmacytoid DC (DC2), which is CD56ϩ CD33-CD11b- [30 -32] .
In conclusion, we have shown that six G-CSF-mobilized peripheral blood CD34ϩ cell products, exposed to lymphocyte growth factors and SCF in the absence of marrow stroma, generate a hierarchy of CD56ϩ cells with NK and myeloid characteristics. These results indicate a hitherto unsuspected diversity of CD34-derived CD56ϩ cells. 
